Health-related quality of life of patients with prostate cancer initiating GnRH agonist therapy: the PRISME study
{{output}}
Objectives: To compare the evolution of health-related quality of life (HRQoL) over 6 months of GnRH agonist (GnRHa) therapy among age groups for patients with prostate cancer (PCa). ... ...
